The U.S. helped pioneer the technology, but new funding cuts may shift breakthroughs — and industry leadership — overseas.

Lyme disease is the most common tick-borne infectious disease in the United States. There is no vaccine to protect against it in humans. Biopharmaceutical company Pfizer and Valne ...

An estimated 475,000 lives were saved in England and Scotland, but the inquiry says a lower vaccine uptake among some groups ...

The people who research, make and invest in vaccines are nervous. Some companies have started pulling back on their vaccine ...

New vaccine momentum reflects growing urgency of avian influenza (H5N1) threat and reinforces need for coordinated global ...

A new human challenge trial under way in Melbourne aims to advance research into Strep A, accelerating efforts toward the development of a vaccine. Subscribe to our newsletter for the latest sci-tech ...

USDA Secretary Brooke Rollins says a vaccine for avian influenza isn’t quite ready for widespread use, but progress is being ...

Oxford and Serum Institute of India have partnered to develop the R78C malaria vaccine. Experts say this next-generation shot ...

UVA Health scientists have developed a promising new way to create vaccines that could be faster, cheaper and easier to distribute than current options. The University of Virginia School of Medicine’s ...

mRNA technology is enabling an entirely new HIV vaccine strategy that, for the first time, successfully primes the immune system toward broadly neutralizing antibodies in humans. The TB vaccine ...